Cargando…
ANMCO Position Paper: the use of non-vitamin K dependent new oral anticoagulant(s) in pulmonary embolism therapy and prevention
The new oral anticoagulants (NOACs) have radically changed the approach to the treatment and prevention of thromboembolic pulmonary embolism. The authors of this position paper face, in succession, issues concerning NOACs, including (i) their mechanism of action, pharmacodynamics, and pharmacokineti...
Autores principales: | Enea, Iolanda, Roncon, Loris, Gulizia, Michele Massimo, Azzarito, Michele, Becattini, Cecilia, Bongarzoni, Amedeo, Casazza, Franco, Cuccia, Claudio, D’Agostino, Carlo, Rugolotto, Matteo, Vatrano, Marco, Vinci, Eugenio, Fenaroli, Paride, Formigli, Dario, Silvestri, Paolo, Nardi, Federico, Vedovati, Maria Cristina, Scherillo, Marino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526474/ https://www.ncbi.nlm.nih.gov/pubmed/28751847 http://dx.doi.org/10.1093/eurheartj/sux026 |
Ejemplares similares
-
ANMCO Position Paper: long-term follow-up of patients with pulmonary thromboembolism
por: D’Agostino, Carlo, et al.
Publicado: (2017) -
ANMCO Position Paper: direct oral anticoagulants for stroke prevention in atrial fibrillation: clinical scenarios and future perspectives
por: Nardi, Federico, et al.
Publicado: (2017) -
ANMCO position paper on the management of hypercholesterolaemia in patients with acute coronary syndrome
por: De Luca, Leonardo, et al.
Publicado: (2023) -
ANMCO Position Paper: diagnostic–therapeutic pathway in patients with hypercholesterolaemia and statin intolerance
por: Gulizia, Michele Massimo, et al.
Publicado: (2017) -
ANMCO Scientific Statement: clinical management of hypercholesterolaemia in patients with acute coronary syndromes
por: Colivicchi, Furio, et al.
Publicado: (2017)